Noticias de BMY_US
Noticias del mercado
Últimas noticias sobre BMY_US — 895 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
The latest clinical news around Bristol-Myers Squibb (BMY) centers on late stage oncology and pulmonary fibrosis programs, featuring new Phase 3 readouts and a packed data slate heading into the 2026 ESMO Congress in Madrid. For investors watching the tape, Bristol-Myers Squibb’s recent clinical updates are landing against a backdrop of firming momentum. A 1-day share price return of 3.08% at a last close of US$63.00 and a year-to-date share price return of 17.85% feed into a 1-year total...
Where should the safety bar be for studies investigating CAR-T therapies for autoimmune conditions?
Bristol, Tempus AI partnering with Pathos AI to advance neurological treatments
Bristol Myers Squibb (BMY) reached $61.48 at the closing of the latest trading day, reflecting a -2.41% change compared to its last close.
Bristol Myers Squibb Co. stock underperforms Friday when compared to competitors
Página 1 de 45